|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Hydralazine#Package and Label Display Panel]] |
| {{Hydralazine}}
| |
| {{CMG}}; {{AE}} {{AK}}
| |
| ==Labels and Packages==
| |
| PACKAGE LABEL - PRINCIPAL DISPLAY - Hydralazine Hydrochloride 1 mL Single Dose Vial Label
| |
| | |
| NDC 63323-614-55
| |
| | |
| NP601401
| |
| | |
| hydrALAZINE HYDROCHLORIDE INJECTION, USP
| |
| 20 mg/mL
| |
| | |
| FOR IM OR IV USE
| |
| | |
| 1 mL Rx only
| |
| | |
| Single Dose Vial
| |
| WARNING: DISCARD UNUSED PORTION.
| |
| | |
| {|
| |
| | [[image:hydra9.jpg|400px|thumb]]
| |
| |}
| |
| | |
| PACKAGE LABEL - PRINCIPAL DISPLAY - Hydralazine Hydrochloride 1 mL Single Dose Vial Tray Label
| |
| NDC 63323-614-55
| |
| | |
| NP601401
| |
| | |
| hydrALAZINE HYDROCHLORIDE INJECTION, USP
| |
| | |
| FOR INTRAMUSCULAR OR INTRAVENOUS USE
| |
| | |
| 20 mg/mL
| |
| | |
| 1 mL Single Dose Vial
| |
| | |
| N+ and NOVAPLUS are registered trademarks of Novation, LLC
| |
| | |
| Rx only
| |
| | |
| {|
| |
| | [[image:hydra10.jpg|400px|thumb]]
| |
| |}
| |
| | |
| <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = HYDRALAZINE HYDROCHLORIDE INJECTION [FRESENIUS KABI USA, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c3797028-c625-4f70-ae69-8a5f6f23f1b8 | publisher = | date = | accessdate = 10 March 2014 }}</ref>
| |
| | |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |